human
pathogen
posit
singl
strand
rna
ssrna
virus
includ
chikungunya
viru
pose
sever
health
problem
mani
neither
effici
vaccin
therapeut
strategi
exist
interfer
propag
viral
enzymat
activ
consid
potenti
target
address
function
viral
macrodomain
conserv
fold
nonstructur
protein
mani
ssrna
virus
macrodomain
close
associ
adpribos
function
metabol
adpribosyl
posttransl
modif
control
variou
cellular
process
includ
dna
repair
transcript
stress
respons
found
viral
macrodomain
possess
broad
hydrolas
activ
toward
monoadpribosyl
substrat
monoadpribosyltransferas
aka
respect
revert
posttransl
modif
vitro
cell
contrast
viral
macrodomain
possess
weak
activ
toward
polyadpribos
chain
synthes
aka
unlik
polyadpribosylglycohydrolas
hydrolyz
polyadpribos
chain
individu
adpribos
unit
cleav
amino
acid
side
chain
adpribos
bond
differ
viral
macrodomain
releas
polyadpribos
chain
distinct
effici
mutat
structur
analys
identifi
key
amino
acid
hydrolas
activ
chikungunya
viral
macrodomain
moreov
induc
innat
immun
mechan
suggest
control
monoadpribosyl
part
hostpathogen
conflict
adpribosyl
describ
posttransl
modif
ptm
adpribos
adpr
moieti
transfer
nad
onto
substrat
protein
releas
nicotinamid
intracellular
adpribosyl
mainli
catalyz
enzym
adpribosyltransferas
diphtheria
toxinlik
artd
famili
also
known
parp
famili
base
biochem
featur
artd
subdivid
three
group
member
first
group
includ
abl
iter
transfer
multipl
adpr
unit
onto
substrat
result
format
long
branch
adpr
polym
par
group
ii
enzym
restrict
monoadpribosyl
maryl
part
due
lack
catalyt
activ
glutam
latter
suggest
use
substrateassist
catalysi
modifi
target
whether
belong
group
ii
despit
catalyt
glutam
somewhat
controversi
requir
analys
acceptor
amino
acid
adpribosyl
still
matter
debat
discrep
biochem
mass
spectrometri
studi
nevertheless
acid
amino
acid
consid
import
acceptor
site
group
ii
enzym
find
strongli
suggest
glutam
main
site
modif
protein
third
group
lost
abil
bind
nad
due
amino
acid
substitut
nad
bind
pocket
therefor
catalyt
inact
recent
evid
defin
reader
domain
capabl
interact
specif
maryl
polyadpribosyl
paryl
substrat
thu
particip
dissemin
inform
associ
ptm
moreov
eras
identifi
hydrolyz
bond
singl
adpr
unit
adpr
modifi
amino
acid
defin
adpribosyl
fulli
revers
ptm
key
protein
fold
involv
read
eras
adpribosyl
macrodomain
evolutionari
conserv
structur
domain
sever
macrodomain
includ
one
core
histon
interact
adpr
polym
other
bind
select
maryl
substrat
shown
macrodomain
macrodomain
murin
macrodomain
poorli
character
suggest
affect
transcript
dna
damag
respons
importantli
macrodomain
possess
enzymat
activ
exampl
macrodomain
polyadpribosylglycohydrolas
parg
degrad
par
chain
wherea
macrodomain
remov
termin
protein
bound
adpr
unit
thu
latter
enzym
hydrolyz
ester
bond
adpr
like
acid
acceptor
amino
acid
togeth
find
document
import
role
macrodomain
fold
regul
adpribosyl
function
metabol
adpribosyl
implic
varieti
biolog
process
includ
dna
repair
chromatin
remodel
mitosi
transcript
signal
grow
bodi
inform
suggest
function
maryl
interfac
host
pathogen
one
hand
maryl
host
protein
catalyz
rang
bacteri
toxin
therebi
promot
pathogenesi
thu
maryl
conserv
mechan
host
protein
modul
promot
virul
hand
accumul
evid
link
intracellular
maryl
innat
immun
respons
infect
human
monocyt
borrelia
burghdorferi
result
elev
express
line
find
express
three
gene
also
induc
interferon
ifn
respons
factor
part
antivir
program
moreov
monitor
ifn
respons
report
gene
construct
defin
type
ifnstimul
gene
induc
upon
stimul
inhibit
alphaviru
replic
furthermor
protein
particip
repress
protein
translat
combin
viral
infect
addit
molecular
cell
biolog
studi
evolutionari
analys
indic
broad
role
adpribosyl
virushost
interact
sever
artd
famili
member
strong
recurr
posit
select
includ
three
artd
famili
member
possess
macrodomain
well
catalyt
inact
latter
well
establish
antivir
immun
defens
interfer
viral
rna
translat
replic
interact
viral
rna
four
ccchtype
zinc
finger
therebi
promot
degrad
taken
togeth
find
strongli
impli
import
function
artd
famili
member
innat
immun
thu
suggest
adpribosyl
function
consequ
contribut
resolut
hostpathogen
conflict
mention
macrodomain
function
reader
well
eras
maryl
fact
macrodomain
also
conserv
domain
nonstructur
protein
posit
singl
strand
rna
ssrna
virus
provid
evid
function
adpribosyl
innat
immun
ssrna
virus
includ
member
alphaviru
genu
chikungunya
viru
chikv
onyongnyong
viru
onnv
sindbi
viru
sinv
venezuelan
equin
enceph
viru
veev
member
orthohepeviru
genu
among
hepat
e
viru
hev
well
member
alphacoronaviru
genu
felin
infecti
periton
viru
fipv
mutant
felin
coronaviru
belong
virus
human
pathogen
exampl
chikv
transmit
mosquito
result
larg
epidem
recent
year
one
effect
sever
joint
pain
last
month
even
year
thu
consider
longterm
effect
human
health
chikv
among
ssrna
virus
one
top
rate
pathogen
need
vaccin
develop
viral
macrodomain
vmd
mention
virus
poorli
character
regard
biochem
properti
biolog
function
vmd
shown
bind
free
adpr
well
par
monophosphatas
adrp
activ
assign
other
moreov
sever
acut
respiratori
syndrom
sar
coronaviru
harbor
two
addit
macrodomain
fold
sarsuniqu
domain
lack
adpr
bind
instead
interact
gquadruplex
recent
adpribosylhydrolas
activ
report
viral
macrodomain
hev
sar
macrodomain
fold
x
domain
veev
sever
find
provid
evid
biolog
relev
vmd
mutat
adpr
bind
region
sinv
macrodomain
nonstructur
protein
impair
viral
replic
neuron
mutat
vmd
adrp
activ
sar
coronaviru
human
coronaviru
result
increas
sensit
antivir
effect
compar
wildtyp
counterpart
moreov
mous
hepat
viru
macrodomain
promot
virul
mice
vmd
thu
seem
critic
viral
pathogenesi
evas
host
immun
respons
evalu
interplay
adpribosyl
vmd
demonstr
gene
encod
target
signal
thu
like
compon
first
line
immun
respons
virus
furthermor
provid
detail
biochem
analysi
divers
vmd
reveal
hydrolas
activ
toward
maryl
protein
contrast
par
chain
poorli
target
test
vmd
focus
chikv
macrodomain
use
bioinformat
approach
combin
inform
obtain
crystal
structur
vmd
complex
adpr
success
gener
mutant
unabl
demaryl
substrat
complementari
vitro
analys
chikv
macrodomain
revert
maryl
cell
novel
enzymat
activ
vmd
strongli
underlin
hypothesi
maryl
function
hostpathogen
interfac
thu
potenti
drug
target
monoartd
regul
interferon
order
identifi
stimuli
drive
express
fragment
promot
rel
start
transcript
clone
basic
luciferas
report
gene
construct
cell
transient
transfect
report
gene
construct
stimul
antivir
defenseinduc
cytokin
stimul
promot
report
gene
construct
dose
depend
manner
fig
accord
previou
find
also
promot
endogen
protein
synthesi
cell
fig
next
analyz
endogen
figur
express
stimul
interferon
fragment
human
promot
rel
start
transcript
clone
front
luciferas
report
gene
construct
transfect
togeth
galactosidas
express
plasmid
cell
stimul
indic
amount
interferon
ifn
h
later
rel
luciferas
activ
determin
mean
valu
sd
three
experi
b
untransfect
cell
treat
parallel
cell
panel
whole
cell
lysat
analyz
express
immunoblot
use
mab
cf
hela
cell
stimul
indic
time
express
mrna
measur
use
rtqpcr
mean
valu
sd
three
experi
protein
analyz
immunoblot
use
mab
panel
c
peptidespecif
pab
panel
e
f
respect
gene
express
stimul
mrna
protein
synthesi
hela
cell
fig
consist
report
gene
assay
similarli
find
express
also
induc
result
elev
mrna
protein
level
hela
cell
fig
f
detect
protein
level
made
use
antibodi
gener
peptid
deriv
sequenc
locat
macrodomain
supplementari
fig
analog
lipopolysaccharid
lp
bacteri
pathogenassoci
molecular
pattern
stimul
mrna
protein
synthesi
differenti
cell
supplementari
fig
undifferenti
cell
data
shown
note
lp
stimul
express
delay
indic
induct
gene
probabl
indirect
rather
direct
activ
ifn
receptor
downstream
signal
event
taken
togeth
result
support
notion
monoartd
like
play
role
first
line
immun
respons
induc
consequ
stimuli
lp
observ
publish
find
let
us
hypothes
function
maryl
immun
defens
pathogen
expand
hypothesi
interest
function
character
vmd
outlin
certain
macrodomain
link
maryl
either
interact
maryl
substrat
remov
modif
therefor
assess
whether
test
vmd
besid
bind
free
adpr
abl
remov
maryl
substrat
hydrolyz
bond
amino
acid
side
chain
ribos
analog
three
cellular
monoadpribosylhydrolas
purifi
tag
fusion
protein
sever
vmd
perform
hydrolas
assay
automodifi
maryl
gstfusion
protein
catalyt
domain
maryl
nemo
substrat
fig
supplementari
fig
protein
maryl
use
pnad
subsequ
incub
indic
macrodomain
fusion
protein
observ
vmd
test
ie
chikv
veev
fipv
sinv
onnv
hev
close
relat
supplementari
fig
capabl
remov
substanti
fraction
plabel
maryl
nemo
min
expect
also
catalyt
activ
wherea
unabl
hydrolyz
maryl
fig
find
suggest
vmd
possess
hydrolas
demaryl
activ
toward
sever
maryl
substrat
includ
nemo
compon
b
signal
transduct
pathway
character
enzymat
reaction
perform
timecours
experi
tag
vmd
chikv
fipv
onnv
sinv
maryl
catalyt
domain
fig
b
supplementari
fig
roughli
half
incorpor
p
label
releas
vmd
within
min
label
min
small
differ
individu
vmd
base
known
interact
vmd
adpr
expect
adpr
competit
inhibitor
vmd
inde
free
adpr
inhibit
hydrolas
activ
chikv
macrodomain
toward
maryl
catalyt
domain
fig
similar
find
observ
inhibitori
effect
adpr
concentr
depend
titrat
chikv
macrodomain
demonstr
robust
hydrolas
activ
even
low
protein
concentr
chikv
macrodomain
revers
maryl
effici
fig
product
releas
chikv
macrodomain
analyz
thin
layer
chromatographi
tlc
found
migrat
ident
product
obtain
pargcattr
automodifi
fig
parg
hydrolys
effici
riboseribosyl
glycosid
bond
adpr
unit
par
chain
gener
adpr
thu
find
consist
releas
adpr
chikv
macrodomain
togeth
result
defin
vmd
adpribosylhydrolas
capabl
effici
revert
monoadpribosyl
catalyz
three
differ
monoartd
polyadpribos
chain
ineffici
hydrolyz
viral
macrodomain
determin
whether
vmd
addit
remov
monoadpr
substrat
also
possess
activ
toward
par
chain
perform
hydrolas
assay
paryl
vitro
cell
fig
supplementari
fig
hatag
transient
express
cell
cell
harvest
immunoprecipit
use
haspecif
antibodi
whole
cell
lysat
autoparyl
immunoprecipit
stimul
addit
doubl
strand
dna
fragment
presenc
nad
subsequ
hydrolas
assay
perform
paryl
measur
use
parspecif
antibodi
fig
quantif
activ
vmd
chikv
fipv
onnv
sinv
show
weak
activ
toward
vitro
paryl
nevertheless
observ
trend
reduct
paryl
fig
moreov
increas
signal
measur
haspecif
antibodi
respons
vmd
chikv
onnv
suggest
molecul
longer
shift
higher
mobil
indic
activ
modifi
fig
see
ha
immunoprecipti
ip
materi
similarli
signific
activ
measur
assay
contrast
incub
catalyt
domain
parg
welldescrib
eras
paryl
macrodomain
fold
result
nearli
complet
loss
par
signal
ha
stain
immunoprecipti
compar
neg
control
incub
absenc
nad
fig
b
find
corrobor
analyz
immunoprecipit
isol
transient
transfect
hela
cell
treat
h
prior
harvest
stimul
intracellular
paryl
fig
immunoblot
analys
indic
modif
obtain
cell
less
substanti
ie
shorter
par
chain
compar
modifi
vitro
compar
panel
c
fig
treatment
cell
inhibitor
olaparib
well
incub
pargcat
serv
control
moreov
olaparib
ad
lysi
buffer
prevent
automodif
cell
lysi
agreement
result
vitro
modifi
paryl
affect
extend
depend
ident
vmd
fig
contrast
vitro
assay
reduct
respons
chikv
onnv
sinv
macrodomain
signific
although
compar
effect
respons
incub
pargcat
fig
direct
comparison
quantifi
mar
level
incub
vmd
min
hydrolysi
fig
result
suggest
vmd
test
consider
effici
demaryl
compar
deparyl
find
summar
fig
obtain
incub
sampl
min
time
cours
experi
differ
vmd
maryl
substrat
demonstr
demaryl
increas
longer
time
period
substanti
almost
complet
loss
modif
min
fig
supplementari
fig
therefor
assess
deparyl
vitro
modifi
macrodomain
chikv
fipv
time
supplementari
fig
chikv
fipv
macrodomain
exhibit
weak
hydrolas
activ
compar
control
incub
min
absenc
vmd
note
latter
incub
min
alreadi
exhibit
substanti
reduct
paryl
compar
start
point
deparyl
automodifi
presenc
pnad
addit
substrat
nemo
includ
panel
modifi
protein
incub
indic
bacteri
express
tag
fusion
protein
differ
macrodomain
min
protein
stain
use
coomassi
blue
cb
radioact
associ
differ
substrat
assess
autoradiographi
p
chikv
chikungunya
viru
veev
venezuelan
equin
enceph
viru
fipv
felin
infecti
periton
viru
hev
hepat
e
virus
strain
onnv
onyongnyong
viru
sinv
sindbi
viru
macrodomain
murin
macrodomain
murin
nonstructur
protein
open
read
frame
protein
cb
coomassi
blue
p
autoradiogram
without
ad
macrodomain
also
seen
other
find
agreement
analysi
releas
product
automodifi
supplementari
fig
incub
absenc
macrodomain
result
releas
adpr
well
par
chain
alreadi
min
measur
protein
incub
macrodomain
indic
time
protein
stain
use
coomassi
blue
cb
radioact
associ
differ
substrat
assess
autoradiographi
p
b
panel
automodifi
catalyt
domain
substrat
c
panel
presenc
increas
amount
adpribos
panel
titrat
serial
dilut
e
immunoprecipit
domain
automodifi
presenc
pnad
protein
incub
pargcat
macrodomain
indic
time
releas
radioact
label
product
analyz
subject
supernat
reaction
thin
layer
chromatographi
tlc
cb
coomassi
blue
tlc
thin
layer
chromatographi
p
autoradiogram
tlc
analysi
slightli
stimul
differ
vmd
except
macrodomain
fipv
supplementari
fig
show
activ
parg
result
complet
hydrolysi
adpr
result
corrobor
analyz
releas
plabel
par
chain
sequenc
gel
remain
proteinbound
par
sdspage
supplementari
fig
c
base
find
suggest
maryl
protein
prefer
substrat
differ
vmd
analyz
appar
least
vmd
gain
access
amino
acid
side
chain
ribos
bond
par
modifi
substrat
thu
remov
complet
par
chain
observ
vmd
hydrolyz
riboseribosyl
glycosid
bond
within
par
chain
contrast
parg
mutat
analysi
chikv
macrodomain
defin
catalyt
import
amino
acid
catalyt
mechan
macrodomain
adpribosylhydrolas
fulli
understood
obtain
inform
amino
acid
relev
catalyt
activ
focus
publish
crystal
structur
chikv
macrodomain
complex
adpr
chosen
structur
inform
macrodomain
complex
maryl
substrat
ie
peptid
protein
report
thu
far
perform
silico
analys
identifi
amino
acid
face
adpr
bind
pocket
contribut
adpr
bind
fig
b
procedur
allow
identifi
import
amino
acid
ligand
recognit
amino
acid
within
distanc
adpr
subject
silico
alanin
scan
obtain
mutant
rank
accord
differ
interact
score
respect
wildtyp
wt
protein
g
valu
fig
three
best
hit
arginin
n
valin
v
tyrosin
sitedirect
mutagenesi
wt
chikv
macrodomain
perform
amino
acid
chang
alanin
tag
fusion
protein
chikv
macrodomain
mutant
purifi
subject
hydrolas
assay
maryl
indic
time
fig
vmd
mutant
show
less
hydrolas
activ
compar
wt
protein
indic
three
identifi
amino
acid
import
substrat
bind
andor
catalysi
still
exhibit
visibl
demaryl
obtain
macrodomain
mutant
substanti
loss
enzymat
activ
evalu
energet
ligandprotein
interact
everi
possibl
amino
acid
substitut
three
posit
supplementari
tabl
base
score
gener
addit
mutant
fig
replac
arginin
r
tyrosin
fig
glutam
e
phenylalanin
f
fig
valin
v
tryptophan
w
fig
subsequ
hydrolas
assay
maryl
substrat
mutant
show
reduc
catalyt
activ
inact
compar
control
incub
absenc
vmd
protein
fig
f
addit
evalu
hydrolas
activ
mutant
toward
paryl
catalyz
therefor
hydrolas
assay
perform
describ
releas
product
analyz
tlc
supplementari
fig
mutant
inact
analog
result
obtain
maryl
domain
substrat
face
adpr
bind
pocket
form
hydrogen
bond
substratelink
ribos
ring
fig
posit
might
also
influenc
recognit
substrat
ie
maryl
protein
mutat
r
hydrogen
bond
lost
addit
mutant
due
predict
tyrosin
rotat
fig
arrow
might
reduc
substrat
bind
moreov
suggest
affect
posit
ligand
consequ
may
also
reduc
substrat
bind
deepli
buri
bind
caviti
form
hydrogen
bond
backbon
nitrogen
diphosph
adpr
fig
hydrogen
bond
maintain
mutant
howev
bulki
amino
acid
like
e
f
replac
might
reduc
access
volum
bind
site
therefor
hamper
correct
bind
substrat
moreov
specif
mutant
neg
charg
e
might
also
introduc
electrostat
repuls
effect
phosphat
group
adpr
although
obviou
crystal
structur
base
molecular
dynam
hydrogen
bond
form
diphosph
well
termin
ribos
ring
adpr
similar
might
also
play
role
substrat
recognit
substitut
v
w
hydrogen
bond
termin
ribos
ring
lost
take
togeth
import
ligand
bind
possibl
substrat
recognit
thu
necessari
enzymat
activ
chikv
macrodomain
obtain
inform
consequ
mutat
regard
structur
integr
macrodomain
fold
purifi
chikv
macrodomain
protein
analyz
use
circular
dichroism
cd
spectroscopi
mutant
show
spectrum
similar
wt
protein
indic
overal
structur
minim
affect
differ
point
mutat
supplementari
fig
c
thu
find
suggest
catalyt
inact
mutant
structur
intact
impair
adpr
possibl
alter
substrat
bind
provid
molecular
explan
biochem
observ
fulllength
possess
hydrolas
activ
similar
isol
vmd
macrodomain
chikv
locat
nterminu
multifunct
protein
partial
character
address
whether
vmd
also
activ
fulllength
chikv
tag
bacteri
express
purifi
test
hydrolas
activ
fig
compar
isol
macrodomain
chikv
fulllength
capabl
revert
maryl
fig
free
adpr
imped
remov
maryl
dosedepend
manner
fig
similar
find
isol
vmd
fig
next
determin
whether
amino
acid
identifi
import
activ
isol
vmd
fig
also
relev
hydrolas
activ
fulllength
fig
inde
substitut
e
v
result
loss
enzymat
activ
final
test
fulllength
vitro
paryl
compar
isol
vmd
measur
weak
hydrolas
activ
fig
e
comparison
quantifi
activ
fulllength
maryl
reveal
substanti
differ
effect
paryl
fig
f
togeth
result
demonstr
chikv
macrodomain
either
part
possess
robust
hydrolas
activ
toward
sever
maryl
substrat
contrast
par
chain
rather
ineffici
hydrolyz
address
whether
chikv
macrodomain
function
cell
coexpress
vmd
fulllength
cell
tool
detect
intracellularli
maryl
protein
use
gfpfusion
protein
macrodomain
previous
identifi
function
bind
modul
specif
maryl
protein
stabli
express
cell
coimmunoprecipit
coip
experi
use
gfpspecif
antibodi
measur
bound
catalyt
inact
mutant
mean
assess
maryl
fig
expect
interact
maryl
poorli
coexpress
chikv
macrodomain
hamper
bind
wherea
coexpress
mutant
reduc
hydrolas
activ
show
littl
effect
bind
depend
maryl
experi
strongli
indic
chikv
macrodomain
capabl
revert
maryl
cell
nonetheless
express
vmd
might
unanticip
consequ
therefor
want
appli
addit
experiment
setup
made
use
antibodi
initi
made
par
found
also
interact
automodifi
maryl
catalyt
domain
fig
thu
addit
coip
experi
analyz
maryl
immunoprecipit
use
adpr
antibodi
observ
signal
overexpress
immunoprecipit
hela
cell
lysat
fig
chikv
macrodomain
coexpress
maryl
reduc
fig
line
experi
coloc
cell
reduc
upon
coexpress
chikv
macrodomain
fig
almost
exclus
associ
dot
reloc
throughout
cell
vmd
coexpress
compar
distribut
presenc
catalyt
inact
note
dot
show
coloc
presenc
chikv
macrodomain
probabl
vmd
unabl
remov
maryl
togeth
find
provid
strong
support
intracellular
hydrolas
activ
chikv
macrodomain
toward
maryl
stimul
cell
defin
target
gene
cytokin
document
elev
mrna
protein
express
fig
repres
first
line
respons
invad
virus
trigger
robust
complex
antivir
cellular
program
induc
ifnstimul
gene
isg
thu
two
monoartd
isg
consist
previou
studi
demonstr
express
gene
induc
respons
pathogen
induct
measur
timecours
experi
occur
delay
suggest
direct
heterotrimer
complex
target
gene
cooper
addit
signal
relev
induc
express
delay
express
indic
role
balanc
immun
respons
part
feedback
loop
monoartd
show
ntermin
local
put
rna
recognit
motif
might
relev
recogn
foreign
rna
invad
pathogen
could
function
signal
develop
appropri
immun
respons
respect
worth
note
interfer
b
signal
pathway
critic
shape
immun
cell
function
addit
find
support
role
artd
antivir
defens
includ
antivir
role
propos
evolut
sever
artd
respons
pathogen
moreov
sever
monoartd
associ
stress
granul
structur
implic
control
replic
virus
furthermor
gener
term
ptm
includ
phosphoryl
ubiquitinyl
fulfil
essenti
role
control
protein
activ
cell
manipul
pathogen
promot
infect
propag
thu
inform
far
monoartd
suggest
maryl
like
target
virus
support
find
vmd
function
monoadpribosylhydrolas
vmd
chikv
onnv
sinv
veev
hev
fipv
possess
demaryl
activ
effici
hydrolyz
par
chain
fig
supplementari
fig
silico
mutat
analysi
well
subsequ
biochem
experi
macrodomain
mutant
adpr
protein
incub
min
c
substitut
amino
acid
fulllength
shown
affect
catalyt
activ
chikv
macrodomain
gener
bacteri
express
purifi
fusion
protein
subject
afor
maryl
indic
time
activ
analyz
describ
panel
express
cell
immunoprecipit
cell
lysat
automodifi
incub
nad
presenc
doubl
strand
oligom
paryl
incub
min
par
chain
evalu
use
parspecif
antibodi
immunoblot
protein
stain
use
coomassi
blue
cb
control
express
tubulin
determin
whole
cell
lysat
wcl
use
immunoblot
e
experi
perform
panel
quantifi
mean
valu
sd
experi
shown
f
quantif
demaryl
measur
min
mean
valu
sd
experi
shown
cb
coomassi
blue
ip
immunoprecipit
wcl
whole
cell
lysat
p
autoradiogram
p
p
ns
signific
unpair
ttest
appli
fusion
protein
read
maryl
transient
transfect
plasmid
express
catalyt
inact
chikv
macrodomain
wt
mutant
indic
cell
lyse
immunoprecipit
use
antigfp
antibodi
protein
g
bead
amount
coimmunoprecipit
determin
immunoblot
mab
express
control
protein
analyz
whole
cell
lysat
wcl
immunoblot
b
incub
presenc
absenc
nad
protein
analyz
immunoblot
use
antipar
antibodi
trevigen
control
blot
stain
ponceau
visual
c
hela
cell
transient
transfect
express
plasmid
indic
immunoprecipit
maryl
determin
immunoblot
use
antipar
antibodi
capabl
detect
maryl
express
control
whole
cell
lysat
wcl
analyz
hela
flpin
cell
transient
transfect
indic
express
induc
local
analyz
confoc
microscopi
shown
green
induc
shown
red
scale
bar
ib
immunoblot
ip
immunoprecipit
wcl
whole
cell
lysat
fulllength
support
novel
enzymat
activ
vmd
fig
test
vmd
appear
elicit
broad
catalyt
activ
demaryl
automodifi
maryl
nemo
substrat
moreov
possibl
substrat
well
modifi
multipl
site
enhanc
substrat
complex
support
interpret
broad
catalyt
activ
also
consist
find
discuss
multipl
monoartd
potenti
associ
antivir
activ
thu
vmd
expect
capabl
demaryl
multipl
substrat
demonstr
also
demaryl
cell
suggest
vmd
function
intracellularli
fig
relev
substrat
need
demaryl
viral
infect
cell
remain
determin
understand
maryl
substrat
limit
present
protein
demonstr
modifi
cell
thu
interest
defin
relev
target
catalyt
activ
vmd
understand
biolog
consequ
maryl
demaryl
potenti
import
viru
propag
vmd
describ
interact
par
chain
take
overal
highli
posit
electrostat
surfac
potenti
vmd
account
bind
neg
charg
molecul
like
par
unexpect
specif
concern
despit
interact
could
detect
substanti
hydrolas
activ
vmd
toward
par
chain
synthes
fig
supplementari
fig
note
linkag
protein
proxim
adpr
ester
bond
acid
amino
acid
differ
riboseribosyl
oglycosid
bond
found
within
par
chain
thu
like
differ
catalyt
mechan
need
either
trim
par
chain
cleav
bond
amino
acid
side
chain
adpr
par
chain
singl
adpr
unit
distinguish
latter
depend
whether
vmd
abl
accommod
amino
acid
ribos
ester
bond
activ
center
despit
one
addit
adpr
unit
bound
amino
acid
link
adpr
par
chain
look
crystal
structur
chikv
macrodomain
complex
adpr
might
possibl
vmd
interact
par
chain
howev
find
suggest
none
test
vmd
includ
one
chikv
strong
activ
paryl
argu
amino
acid
ribos
ester
bond
par
chain
less
well
access
andor
posit
activ
center
compar
respect
bond
maryl
substrat
consequ
complet
par
chain
less
effici
releas
monoadpr
substrat
work
consider
report
publish
suggest
vmd
hydrolyz
maryl
paryl
note
result
suggest
activ
par
chain
easi
interpret
due
signific
background
experi
moreov
padpribosyl
low
nad
condit
shown
other
also
result
substanti
maryl
addit
paryl
thu
releas
radioact
label
might
least
part
due
hydrolysi
maryl
consist
find
vmd
test
significantli
activ
toward
maryl
compar
paryl
fig
supplementari
fig
addit
aspect
worth
consid
relat
find
report
modifi
acid
amino
acid
also
lysin
thu
might
vmd
remov
par
chain
glutam
aspart
lysin
biochem
reaction
would
expect
rather
distinct
togeth
find
strongli
suggest
vmd
evolv
specif
demaryl
enzym
base
silico
analysi
chikv
macrodomain
amino
acid
suggest
import
ligand
bind
thu
like
catalyt
activ
fig
date
precis
valid
catalyt
mechan
explain
remov
proteinproxim
adpr
lack
experiment
result
obtain
chikv
macrodomain
mutant
base
silico
alanin
scan
calcul
amber
score
also
agreement
molecular
dynam
simul
propos
chikv
macrodomain
import
enzymesubstr
interact
catalysi
shown
inactiv
mutat
includ
affect
overal
structur
chikv
macrodomain
supplementari
fig
import
address
biolog
relev
viral
replic
respect
report
find
hev
macrodomain
mutat
worth
discuss
strong
effect
replic
observ
tripl
mutat
show
reduc
bind
par
chain
interest
determin
whether
due
reduc
catalyt
activ
alter
structur
macrodomain
latter
could
effect
overal
function
inde
macrodomain
hev
interact
nonstructur
protein
suggest
function
relev
viral
replic
might
abolish
structur
chang
note
also
motif
hev
conserv
vmd
eg
sinv
geg
veev
ggg
chikv
gdg
onnv
gdg
fipv
vgg
within
motif
respect
aspart
chikv
macrodomain
consid
silico
analysi
substitut
alanin
result
highli
neg
g
valu
suggest
chang
would
rather
stabil
interact
adpribos
therefor
evalu
fig
conclus
find
demonstr
sever
macrodomain
differ
genera
ssrna
virus
possess
monoadpribosylhydrolas
activ
divers
substrat
suggest
togeth
respons
sever
monoartd
well
publish
find
maryl
ptm
relev
innat
immun
respons
previou
studi
substrat
suggest
multipl
signal
pathway
regul
maryl
howev
potenti
substrat
function
consequ
maryl
known
strinkingli
substrat
maryl
probabl
even
identifi
also
monoartd
control
beyond
effect
gene
transcript
poorli
understood
taken
togeth
highlight
maryl
ptm
emerg
relev
potenti
import
role
viral
defens
gener
hostpathogen
conflict
cell
line
cell
cultur
hela
flpin
hela
flpin
cell
cultiv
dmem
supplement
heatinactiv
fetal
calf
serum
fc
rpmi
fc
co
transfect
perform
use
calcium
phosphat
precipit
techniqu
flpin
trex
cell
transfect
plasmid
contain
respect
bind
dead
mutant
invitrogen
select
use
gml
blasticidin
invivogen
gml
hygromycin
b
invivogen
reagent
antibodi
follow
reagent
use
nad
sigma
report
gene
assay
measur
promot
activ
cell
seed
plate
transient
transfect
promot
report
gene
construct
normal
transfect
effici
galactosidas
express
plasmid
cotransfect
h
transfect
cell
stimul
h
subsequ
harvest
use
extract
buffer
mm
tri
ph
mm
edta
glycerol
triton
mm
dtt
luciferas
activ
normal
galactosidas
activ
quantit
realtim
pcr
immunoblot
analysi
hela
cell
stimul
uml
cell
differenti
pma
ngml
h
stimul
lp
ngml
total
rna
isol
use
high
pure
rna
isol
kit
roch
accord
manufactur
protocol
revers
transcript
perform
g
rna
use
quantitect
revers
transcript
kit
qiagen
express
analyz
quantit
realtim
pcr
qrtpcr
use
quantitect
primer
assay
qiagen
experi
mrna
express
gene
interest
normal
gu
quantitect
primer
assay
qiagen
protein
analysi
cell
treat
harvest
ripa
buffer
mm
tri
ph
mm
nacl
doc
sd
pic
cellular
debri
remov
centrifug
min
lysat
fraction
use
sdspage
analyz
immunoblot
clone
mutagenesi
cdna
encod
bp
long
fragment
human
promot
rel
start
transcript
gener
hela
dna
use
sequenc
specif
primer
harbor
restrict
site
hindiii
ncoi
fragment
clone
front
luciferas
report
gene
report
gene
construct
gstfusion
protein
describ
previous
cdna
encod
catalyt
domain
well
gener
plasmid
obtain
h
stockholm
clone
use
gateway
clone
strategi
bacteri
express
construct
tag
fusion
protein
viral
macrodomain
chikv
fipv
veev
obtain
b
coutard
marseil
plasmid
encod
viral
macrodomain
sinv
onnv
gener
lic
clone
clone
express
viral
macrodomain
mutant
thereof
gener
gateway
clone
mutant
gener
use
standard
mutagenesi
procedur
confirm
sequenc
kind
gift
hottig
purif
hisand
gsttag
fusion
protein
gsttag
fusion
protein
express
e
coli
except
macrodomain
express
e
coli
purif
recombin
protein
achiev
use
affin
chromatographi
either
glutathionesepharos
gstfusion
protein
talon
metal
affin
resin
fusion
protein
accord
standard
protocol
hydrolas
assay
immunoprecipit
cell
transient
transfect
plasmid
encod
cell
harvest
tap
lysi
buffer
mm
tri
ph
mm
nacl
mm
edta
glycerol
mm
dtt
pic
lysat
centrifug
min
immunoprecipit
l
antiha
covanc
antibodi
protein
g
bead
h
thereaft
bead
wash
tap
lysi
buffer
reaction
buffer
mm
tri
ph
mm
tcep
mm
mgcl
adpribosyl
carri
l
reaction
buffer
supplement
nad
depend
age
pnad
pmol
anneal
doubl
strand
oligom
min
reaction
stop
wash
reaction
buffer
g
respect
purifi
tag
vmd
ad
incub
min
reaction
analyz
sdspage
immunoblot
endogen
paryl
hela
cell
transient
transfect
plasmid
express
prior
harvest
cell
treat
mm
h
min
promot
paryl
control
cell
incub
olaparib
h
